Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine

David W. Dodick, Giorgio Sandrini, Paul Williams

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine'. Together they form a unique fingerprint.

Medicine & Life Sciences